{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:34:28Z","timestamp":1783110868640,"version":"3.54.6"},"reference-count":66,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2025-0008_abs_001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an innovative intraperitoneal drug delivery technique utilizing a nebulizer to aerosolize liquid chemotherapy agents under pressure, distributing them evenly throughout the peritoneal cavity to achieve therapeutic effects. As increasing clinical evidence supports the safety and efficacy of PIPAC as a promising treatment for peritoneal metastasis, optimizing nebulizer technology to enhance treatment outcomes has garnered significant research interest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0008_abs_002\">\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>Following initial investigations into the internal structure, mechanical properties, and optimization parameters of the original PIPAC nebulizer, researchers worldwide have focused on refining nebulizer design and exploring innovative applications of aerosolization devices, resulting in the development of several clinically applicable nebulizers with distinct characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0008_abs_003\">\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>This review aims to provide a comprehensive examination of the global advancements in PIPAC nebulizer development, the nebulizer alternative devices, evaluation parameters and methods, as well as future research directions, aiming to inform the development, optimization, and application of novel nebulizers for PIPAC, thereby contributing to the advancement of this promising therapeutic approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0008_abs_004\">\n                    <jats:title>Outlook<\/jats:title>\n                    <jats:p>Current methods for evaluating nebulizer performance are continually being refined, and the integration of nebulizers with other physical modalities holds great promise for further improving PIPAC outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2025-0008","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:44:08Z","timestamp":1762411448000},"page":"153-162","source":"Crossref","is-referenced-by-count":1,"title":["Advancements in nebulizers for pressurized intraperitoneal aerosol chemotherapy (PIPAC)"],"prefix":"10.1515","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3767-9609","authenticated-orcid":false,"given":"Xiaosong","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery , Jieyang People\u2019s Hospital , Jieyang , China"},{"name":"Department of Gastrointestinal Surgery, Department of General Surgery , Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Department of General Surgery , Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Department of General Surgery , Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2025121816430082005_j_pp-2025-0008_ref_001","doi-asserted-by":"crossref","unstructured":"Solass, W, Kerb, R, M\u00fcrdter, T, Giger-Pabst, U, Strumberg, D, Tempfer, C, et al.. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 2014;21:553\u20139. https:\/\/doi.org\/10.1245\/s10434-013-3213-1.","DOI":"10.1245\/s10434-013-3213-1"},{"key":"2025121816430082005_j_pp-2025-0008_ref_002","doi-asserted-by":"crossref","unstructured":"Alyami, M, H\u00fcbner, M, Grass, F, Bakrin, N, Villeneuve, L, Laplace, N, et al.. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol 2019;20:e368\u201377. https:\/\/doi.org\/10.1016\/S1470-2045-19-30318-3.","DOI":"10.1016\/S1470-2045(19)30318-3"},{"key":"2025121816430082005_j_pp-2025-0008_ref_003","doi-asserted-by":"crossref","unstructured":"Alyami, M, Mercier, F, Siebert, M, Bonnot, PE, Laplace, N, Villeneuve, L, et al.. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 2021;47:128\u201333. https:\/\/doi.org\/10.1016\/j.ejso.2019.06.028.","DOI":"10.1016\/j.ejso.2019.06.028"},{"key":"2025121816430082005_j_pp-2025-0008_ref_004","doi-asserted-by":"crossref","unstructured":"Daniel, SK, Sun, BJ, Lee, B. PIPAC for gastrointestinal malignancies. J\u00a0Clin Med 2023;12:6799. https:\/\/doi.org\/10.3390\/jcm12216799.","DOI":"10.3390\/jcm12216799"},{"key":"2025121816430082005_j_pp-2025-0008_ref_005","doi-asserted-by":"crossref","unstructured":"Waheed, MT, Ruel, N, Whelan, RL, Fakih, M, Fong, Y, Deperalta, D, et al.. Impact of PIPAC-oxaliplatin on functional recovery, good days, and survival in a refractory colorectal and appendiceal carcinomatosis: secondary analysis of the US PIPAC collaborative phase 1 trial. Ann Surg Oncol 2024;31:7998\u20138007. https:\/\/doi.org\/10.1245\/s10434-024-15980-9.","DOI":"10.1245\/s10434-024-15980-9"},{"key":"2025121816430082005_j_pp-2025-0008_ref_006","doi-asserted-by":"crossref","unstructured":"Di Giorgio, A, Macr\u00ec, A, Ferracci, F, Robella, M, Visaloco, M, De Manzoni, G, et al.. 10\u00a0years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis. Cancers 2023;15:1125. https:\/\/doi.org\/10.3390\/cancers15041125.","DOI":"10.3390\/cancers15041125"},{"key":"2025121816430082005_j_pp-2025-0008_ref_007","doi-asserted-by":"crossref","unstructured":"Sola\u00df, W, Hetzel, A, Nadiradze, G, Sagynaliev, E, Reymond, MA. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc 2012;26:1849\u201355. https:\/\/doi.org\/10.1007\/s00464-012-2148-0.","DOI":"10.1007\/s00464-012-2148-0"},{"key":"2025121816430082005_j_pp-2025-0008_ref_008","doi-asserted-by":"crossref","unstructured":"Nadiradze, G, Horvath, P, Sautkin, Y, Archid, R, Weinreich, FJ, K\u00f6nigsrainer, A, et al.. Overcoming drug resistance by taking advantage of physical principles: Pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers 2019;12:34. https:\/\/doi.org\/10.3390\/cancers12010034.","DOI":"10.3390\/cancers12010034"},{"key":"2025121816430082005_j_pp-2025-0008_ref_009","doi-asserted-by":"crossref","unstructured":"Reymond, MA, Hu, B, Garcia, A, Reck, T, K\u00f6ckerling, F, Hess, J, et al.. Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator. Surg Endosc 2000;14:51\u20135. https:\/\/doi.org\/10.1007\/s004649900010.","DOI":"10.1007\/s004649900010"},{"key":"2025121816430082005_j_pp-2025-0008_ref_010","doi-asserted-by":"crossref","unstructured":"Solass, W, Herbette, A, Schwarz, T, Hetzel, A, Sun, JS, Dutreix, M, et al.. Therapeutic approach of human peritoneal carcinomatosis with dbait in combination with capnoperitoneum: proof of concept. Surg Endosc 2012;26:847\u201352. https:\/\/doi.org\/10.1007\/s00464-011-1964-y.","DOI":"10.1007\/s00464-011-1964-y"},{"key":"2025121816430082005_j_pp-2025-0008_ref_011","doi-asserted-by":"crossref","unstructured":"Blanco, A, Giger-Pabst, U, Solass, W, Zieren, J, Reymond, MA. Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol 2013;20:2311\u201316. https:\/\/doi.org\/10.1245\/s10434-012-2840-2.","DOI":"10.1245\/s10434-012-2840-2"},{"key":"2025121816430082005_j_pp-2025-0008_ref_012","unstructured":"CapnoPen\u00a0\u2013\u00a0CapnoPharm. [Accessed Jan 3\u00a02025]. https:\/\/capnopharm.com\/capnopen-2\/"},{"key":"2025121816430082005_j_pp-2025-0008_ref_013","doi-asserted-by":"crossref","unstructured":"Sgarbura, O, Eveno, C, Alyami, M, Bakrin, N, Guiral, DC, Ceelen, W, et al.. Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC). Pleura Peritoneum 2022;7:1\u20137. https:\/\/doi.org\/10.1515\/pp-2022-0102.","DOI":"10.1515\/pp-2022-0102"},{"key":"2025121816430082005_j_pp-2025-0008_ref_014","doi-asserted-by":"crossref","unstructured":"Taibi, A, Sgarbura, O, H\u00fcbner, M, Bardet, SM, Alyami, M, Bakrin, N, et al.. Feasibility and safety of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy with or without intraoperative intravenous 5-Fluorouracil and leucovorin for colorectal peritoneal metastases: a multicenter comparative cohort study. Ann Surg Oncol 2022;29:5243\u201351. https:\/\/doi.org\/10.1245\/s10434-022-11577-2.","DOI":"10.1245\/s10434-022-11577-2"},{"key":"2025121816430082005_j_pp-2025-0008_ref_015","doi-asserted-by":"crossref","unstructured":"Khosrawipour, V, Khosrawipour, T, Diaz-Carballo, D, F\u00f6rster, E, Zieren, J, Giger-Pabst, U, et al.. Exploring the spatial drug distribution pattern of pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol 2016;23:1220\u20134. https:\/\/doi.org\/10.1245\/s10434-015-4954-9.","DOI":"10.1245\/s10434-015-4954-9"},{"key":"2025121816430082005_j_pp-2025-0008_ref_016","doi-asserted-by":"crossref","unstructured":"Khosrawipour, V, Khosrawipour, T, Falkenstein, TA, Diaz-Carballo, D, F\u00f6rster, E, Osma, A, et al.. Evaluating the effect of micropump\u00a9 position, internal pressure and doxorubicin dosage on efficacy of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an Ex\u00a0vivo model. Anticancer Res 2016;36:4595\u2013600. https:\/\/doi.org\/10.21873\/anticanres.11008.","DOI":"10.21873\/anticanres.11008"},{"key":"2025121816430082005_j_pp-2025-0008_ref_017","doi-asserted-by":"crossref","unstructured":"Khosrawipour, V, Khosrawipour, T, Kern, AJP, Osma, A, Kabakci, B, Diaz-Carballo, D, et al.. Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model. J\u00a0Cancer Res Clin Oncol 2016;142:2275\u201380. https:\/\/doi.org\/10.1007\/s00432-016-2234-0.","DOI":"10.1007\/s00432-016-2234-0"},{"key":"2025121816430082005_j_pp-2025-0008_ref_018","doi-asserted-by":"crossref","unstructured":"Bellendorf, A, Khosrawipour, V, Khosrawipour, T, Siebigteroth, S, Cohnen, J, Diaz-Carballo, D, et al.. Scintigraphic peritoneography reveals a non-uniform 99mTc-Pertechnetat aerosol distribution pattern for pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in a swine model. Surg Endosc 2018;32:166\u201374. https:\/\/doi.org\/10.1007\/s00464-017-5652-4.","DOI":"10.1007\/s00464-017-5652-4"},{"key":"2025121816430082005_j_pp-2025-0008_ref_019","doi-asserted-by":"crossref","unstructured":"G\u00f6hler, D, Khosrawipour, V, Khosrawipour, T, Diaz-Carballo, D, Falkenstein, TA, Zieren, J, et al.. Technical description of the microinjection pump (MIP\u00ae) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc 2017;31:1778\u201384. https:\/\/doi.org\/10.1007\/s00464-016-5174-5.","DOI":"10.1007\/s00464-016-5174-5"},{"key":"2025121816430082005_j_pp-2025-0008_ref_020","doi-asserted-by":"crossref","unstructured":"Khosrawipour, T, Wu, D, Alex. Feasibility of single tumorspot treatment in peritoneal carcinomatosis via close range doxorubicin impaction in pressurized intra-peritoneal aerosol chemotherapy (PIPAC). J\u00a0Clin Exp Oncol 2017;6. https:\/\/doi.org\/10.4172\/2324-9110.1000187.","DOI":"10.4172\/2324-9110.1000187"},{"key":"2025121816430082005_j_pp-2025-0008_ref_021","doi-asserted-by":"crossref","unstructured":"G\u00f6hler, D, Stintz, M. Granulometric characterization of airborne particulate release during spray application of nanoparticle-doped coatings. J\u00a0Nanoparticle Res Interdiscip Forum Nanoscale Sci Technol 2014;16:2520. https:\/\/doi.org\/10.1007\/s11051-014-2520-1.","DOI":"10.1007\/s11051-014-2520-1"},{"key":"2025121816430082005_j_pp-2025-0008_ref_022","doi-asserted-by":"crossref","unstructured":"G\u00f6hler, D, Oelschl\u00e4gel, K, Ouaissi, M, Giger-Pabst, U. Performance of different nebulizers in clinical use for pressurized intraperitoneal aerosol chemotherapy (PIPAC). PLoS One 2024;19:e0300241. https:\/\/doi.org\/10.1371\/journal.pone.0300241.","DOI":"10.1371\/journal.pone.0300241"},{"key":"2025121816430082005_j_pp-2025-0008_ref_023","doi-asserted-by":"crossref","unstructured":"Pocard, M, Mimouni, M, Richard, C, Adenot, P, Huchon, C, Chavatte-Palmer, P, et al.. Nebulization is less effective than aerosolization, in PIPAC live animal drug delivery testing. Surg Open Dig Adv 2023;9:100078. https:\/\/doi.org\/10.1016\/j.soda.2022.100078.","DOI":"10.1016\/j.soda.2022.100078"},{"key":"2025121816430082005_j_pp-2025-0008_ref_024","doi-asserted-by":"crossref","unstructured":"Braet, H, Andretto, V, Mari\u00ebn, R, Y\u00fccesan, B, van der Vegte, S, Haegebaert, R, et al.. The effect of electrostatic high pressure nebulization on the stability, activity and ex\u00a0vivo distribution of ionic self-assembled nanomedicines. Acta Biomater 2023;170:318\u201329. https:\/\/doi.org\/10.1016\/j.actbio.2023.08.027.","DOI":"10.1016\/j.actbio.2023.08.027"},{"key":"2025121816430082005_j_pp-2025-0008_ref_025","doi-asserted-by":"crossref","unstructured":"Kockelmann, F, G\u00f6hler, D, Barbey, S. Chemical\/technical risk analysis of a new multi-directional nebulizer (MDN) and its clinical implementation for the safe administration of pressurized intraperitoneal aerosol chemotherapy (MDN-PIPAC)[J\/OL]. medRxiv, medRxiv 2023.12.01.23297348. Posted 2023-12-15. https:\/\/doi.org\/10.1101\/2023.12.01.23297348 [Accessed 12 Jul 2024].","DOI":"10.1101\/2023.12.01.23297348"},{"key":"2025121816430082005_j_pp-2025-0008_ref_026","doi-asserted-by":"crossref","unstructured":"Mortensen, MB, Glehen, O, Horvath, P, H\u00fcbner, M, Hyung-Ho, K, K\u00f6nigsrainer, A, et al.. The ISSPP PIPAC database: design, process, access, and first interim analysis. Pleura Peritoneum 2021;6:91\u20137. https:\/\/doi.org\/10.1515\/pp-2021-0108.","DOI":"10.1515\/pp-2021-0108"},{"key":"2025121816430082005_j_pp-2025-0008_ref_027","doi-asserted-by":"crossref","unstructured":"Mortensen, MB, Casella, F, D\u00fczg\u00fcn, \u00d6, Glehen, O, Hewett, P, H\u00fcbner, M, et al.. Second annual report from the ISSPP PIPAC database. Pleura Peritoneum 2023;8:141\u20136. https:\/\/doi.org\/10.1515\/pp-2023-0047.","DOI":"10.1515\/pp-2023-0047"},{"key":"2025121816430082005_j_pp-2025-0008_ref_028","doi-asserted-by":"crossref","unstructured":"Sautkin, Y, Weinreich, J, Reymond, MA. A multi-nozzle nebuliser does not improve tissue drug delivery during PIPAC. Surg Endosc. 2024;38:5832\u201341. https:\/\/doi.org\/10.1007\/s00464-024-11172-4. Epub 2024 Aug 19.","DOI":"10.1007\/s00464-024-11172-4"},{"key":"2025121816430082005_j_pp-2025-0008_ref_029","doi-asserted-by":"crossref","unstructured":"Hoskovec, D, Dytrych, P, Vocka, M, Krska, Z, Skala, R. MCR-4 TOPOL\u00ae new device for PIPAC\u00a0\u2013\u00a0first clinical use. Eur J Surg Oncol 2022;48:e155. https:\/\/doi.org\/10.1016\/j.ejso.2021.12.308.","DOI":"10.1016\/j.ejso.2021.12.308"},{"key":"2025121816430082005_j_pp-2025-0008_ref_030","unstructured":"MCR-4 TOPOL. Skala. [Accessed Jan 3\u00a02025]. https:\/\/www.skala.cz\/zh\/mcr-4-topol-2\/"},{"key":"2025121816430082005_j_pp-2025-0008_ref_031","doi-asserted-by":"crossref","unstructured":"Djelil, D, Fawaz, J, Laroche, S, Fratea, S, Pocard, M. First clinical evaluation report of using the topol device to deliver PIPAC treatment. Surg Open Dig Adv 2023;11:100108. https:\/\/doi.org\/10.1016\/j.soda.2023.100108.","DOI":"10.1016\/j.soda.2023.100108"},{"key":"2025121816430082005_j_pp-2025-0008_ref_032","unstructured":"HurriChem (CE). ThermaSolutions\u00a0\u2013\u00a0hyperthermic intraperitoneal chemotherapy. https:\/\/www.thermasolutions.com\/hurrichem-c-e\/ [Accessed 3 Jan 2025]."},{"key":"2025121816430082005_j_pp-2025-0008_ref_033","doi-asserted-by":"crossref","unstructured":"Robella, M, Vaira, M, De Simone, M. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis. World J Surg Oncol 2016;14:128. https:\/\/doi.org\/10.1186\/s12957-016-0892-7.","DOI":"10.1186\/s12957-016-0892-7"},{"key":"2025121816430082005_j_pp-2025-0008_ref_034","doi-asserted-by":"crossref","unstructured":"Seitenfus, R, Ferreira, PRW, Santos, GOD, Alves, RJV, Kalil, AN, Barros, ED, et al.. A prototype single-port device for pressurized intraperitoneal aerosol chemotherapy. Technical feasibility and local drug distribution. Acta Cir Bras 2017;32:1056\u201363. https:\/\/doi.org\/10.1590\/s0102-865020170120000007.","DOI":"10.1590\/s0102-865020170120000007"},{"key":"2025121816430082005_j_pp-2025-0008_ref_035","doi-asserted-by":"crossref","unstructured":"Seitenfus, R, Kalil, AN, de-Barros, ED, Fedrizzi, G. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) through a single port: alternative delivery for the control of peritoneal metastases. Rev Col Bras Cir 2018;45:e1909. https:\/\/doi.org\/10.1590\/0100-6991e-20181909.","DOI":"10.1590\/0100-6991e-20181909"},{"key":"2025121816430082005_j_pp-2025-0008_ref_036","doi-asserted-by":"crossref","unstructured":"Seitenfus, R, Kalil, AN, de, BED, Galeano Zettler, C, dos Santos, GO, Glehen, O, et al.. Assessment of the aerosol distribution pattern of a single-port device for intraperitoneal administration of therapeutic substances. Surg Endosc 2019;33:3503\u201310. https:\/\/doi.org\/10.1007\/s00464-019-07043-y.","DOI":"10.1007\/s00464-019-07043-y"},{"key":"2025121816430082005_j_pp-2025-0008_ref_037","unstructured":"Solu\u00e7\u00f5es bhio supply\u00a0\u2013\u00a0bhio supply. [Accessed Jan 3\u00a02025]. http:\/\/www.bhiosupply.com.br\/solucoes-bhio-supply\/"},{"key":"2025121816430082005_j_pp-2025-0008_ref_038","doi-asserted-by":"crossref","unstructured":"Lee, HS, Kim, J, Lee, EJ, Park, SJ, Mun, J, Paik, H, et al.. Evaluation of a novel prototype for pressurized intraperitoneal aerosol chemotherapy. Cancers 2020;12:633. https:\/\/doi.org\/10.3390\/cancers12030633.","DOI":"10.3390\/cancers12030633"},{"key":"2025121816430082005_j_pp-2025-0008_ref_039","doi-asserted-by":"crossref","unstructured":"Park, SJ, Lee, EJ, Lee, HS, Kim, J, Ham, J. Development of rotational intraperitoneal pressurized aerosol chemotherapy to enhance drug delivery into the peritoneum. Drug Deliv 2021;28:1179\u201387. https:\/\/doi.org\/10.1080\/10717544.2021.1937382.","DOI":"10.1080\/10717544.2021.1937382"},{"key":"2025121816430082005_j_pp-2025-0008_ref_040","doi-asserted-by":"crossref","unstructured":"Mun, J, Park, SJ, Kim, HS. Rotational intraperitoneal pressurized aerosol chemotherapy in a porcine model. Gland Surg 2021;10:1271\u20135. https:\/\/doi.org\/10.21037\/gs-2019-ursoc-11.","DOI":"10.21037\/gs-2019-ursoc-11"},{"key":"2025121816430082005_j_pp-2025-0008_ref_041","doi-asserted-by":"crossref","unstructured":"Hwang, DW, Lee, EJ, Chung, JY, Kim, D, Oh, SH. Optimal nozzle position and patient\u2019s posture to enhance drug delivery into the peritoneum during rotational intraperitoneal pressurized aerosol chemotherapy in a swine model. J\u00a0Pers Med 2022;12:1799. https:\/\/doi.org\/10.3390\/jpm12111799.","DOI":"10.3390\/jpm12111799"},{"key":"2025121816430082005_j_pp-2025-0008_ref_042","doi-asserted-by":"crossref","unstructured":"Jung, W, Park, M, Park, SJ, Lee, EJ, Kim, HS, Chung, SH, et al.. Occupational exposure during intraperitoneal pressurized aerosol chemotherapy using doxorubicin in a pig model. Saf Health Work 2023;14:237\u201342. https:\/\/doi.org\/10.1016\/j.shaw.2023.04.002.","DOI":"10.1016\/j.shaw.2023.04.002"},{"key":"2025121816430082005_j_pp-2025-0008_ref_043","doi-asserted-by":"crossref","unstructured":"G\u00f6hler, D, Gro\u00dfe, S, Bellendorf, A, Falkenstein, TA, Ouaissi, M, Zieren, J, et al.. Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): technical description, experimental validation and first proof of concept. Beilstein J Nanotechnol 2017;8:2729\u201340. https:\/\/doi.org\/10.3762\/bjnano.8.272.","DOI":"10.3762\/bjnano.8.272"},{"key":"2025121816430082005_j_pp-2025-0008_ref_044","doi-asserted-by":"crossref","unstructured":"Khosrawipour, V, Mikolajczyk, A, Schubert, J, Khosrawipour, T. Pressurized intra-peritoneal aerosol chemotherapy (PIPAC) via endoscopical microcatheter system. Anticancer Res 2018;38:3447\u201352. https:\/\/doi.org\/10.21873\/anticanres.12613.","DOI":"10.21873\/anticanres.12613"},{"key":"2025121816430082005_j_pp-2025-0008_ref_045","doi-asserted-by":"crossref","unstructured":"Mikolajczyk, A, Khosrawipour, V, Schubert, J, Grzesiak, J, Chaudhry, H, Pigazzi, A, et al.. Effect of liposomal doxorubicin in pressurized intra-peritoneal aerosol chemotherapy (PIPAC). J\u00a0Cancer 2018;9:4301\u20135. https:\/\/doi.org\/10.7150\/jca.26860.","DOI":"10.7150\/jca.26860"},{"key":"2025121816430082005_j_pp-2025-0008_ref_046","doi-asserted-by":"crossref","unstructured":"Mikolajczyk, A, Khosrawipour, V, Schubert, J, Chaudhry, H, Pigazzi, A, Khosrawipour, T, et al.. Particle stability during pressurized intra-peritoneal aerosol chemotherapy (PIPAC). Anticancer Res 2018;38:4645\u20139. https:\/\/doi.org\/10.21873\/anticanres.12769.","DOI":"10.21873\/anticanres.12769"},{"key":"2025121816430082005_j_pp-2025-0008_ref_047","doi-asserted-by":"crossref","unstructured":"Khosrawipour, T, Pigazzi, A, Chaudhry, H, Mikolajczyk, A, Schubert, J, Khosrawipour, V, et al.. Occupational health risk of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) via endoscopical microcatheter system. J\u00a0Clin Oncol. 2019;37:e14231-e14231. https:\/\/doi.org\/10.1200\/JCO.2019.37.15-suppl_e14231","DOI":"10.1200\/JCO.2019.37.15_suppl.e14231"},{"key":"2025121816430082005_j_pp-2025-0008_ref_048","doi-asserted-by":"crossref","unstructured":"Toussaint, L, Sautkin, Y, Illing, B, Weinreich, FJ, Nadiradze, G, K\u00f6nigsrainer, A, et al.. Comparison between microcatheter and nebulizer for generating pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc 2021;35:1636\u201343. https:\/\/doi.org\/10.1007\/s00464-020-07546-z.","DOI":"10.1007\/s00464-020-07546-z"},{"key":"2025121816430082005_j_pp-2025-0008_ref_049","doi-asserted-by":"crossref","unstructured":"Galindo-Filho, VC, Alcoforado, L, Rattes, C, Paiva, DN, Brand\u00e3o, SCS, Fink, JB, et al.. A mesh nebulizer is more effective than jet nebulizer to nebulize bronchodilators during non-invasive ventilation of subjects with COPD: a randomized controlled trial with radiolabeled aerosols. Respir Med 2019;153:60\u20137. https:\/\/doi.org\/10.1016\/j.rmed.2019.05.016.","DOI":"10.1016\/j.rmed.2019.05.016"},{"key":"2025121816430082005_j_pp-2025-0008_ref_050","doi-asserted-by":"crossref","unstructured":"H\u00f6ltzcke, P, Sautkin, I, Clere, S, Castagna, A, K\u00f6nigsrainer, A, Pott, PP, et al.. Feasibility of pressurized intra peritoneal aerosol chemotherapy using an ultrasound aerosol generator (usPIPAC). Surg Endosc 2022;36:7848\u201358. https:\/\/doi.org\/10.1007\/s00464-022-09525-y.","DOI":"10.1007\/s00464-022-09525-y"},{"key":"2025121816430082005_j_pp-2025-0008_ref_051","doi-asserted-by":"crossref","unstructured":"Sautkin, I, Solass, W, Weinreich, FJ, K\u00f6nigsrainer, A, Schenk, M, Thiel, K, et al.. A real-time ex\u00a0vivo model (eIBUB) for optimizing intraperitoneal drug delivery as an alternative to living animal models. Pleura Peritoneum 2019;4:20190017. https:\/\/doi.org\/10.1515\/pp-2019-0017.","DOI":"10.1515\/pp-2019-0017"},{"key":"2025121816430082005_j_pp-2025-0008_ref_052","doi-asserted-by":"crossref","unstructured":"Braet, H, Fransen, PP, Mari\u00ebn, R, Lollo, G, Ceelen, W, Vervaet, C, et al.. CO2-Driven nebulization of pH-Sensitive supramolecular polymers for intraperitoneal hydrogel formation and the treatment of peritoneal metastasis. ACS Appl Mater Interfaces 2023. https:\/\/doi.org\/10.1021\/acsami.3c11274. Published online October 11.","DOI":"10.1021\/acsami.3c11274"},{"key":"2025121816430082005_j_pp-2025-0008_ref_053","doi-asserted-by":"crossref","unstructured":"Pocard, M, So, JBY, Huchon, C, Robella, M, Chavatte-Palmer, P, Eveno, C, et al.. PIPAC nebulizer: how to test the new devices in the market, expert recommendations. J\u00a0Visc Surg 2023;160:52\u20134. https:\/\/doi.org\/10.1016\/j.jviscsurg.2022.10.001.","DOI":"10.1016\/j.jviscsurg.2022.10.001"},{"key":"2025121816430082005_j_pp-2025-0008_ref_054","doi-asserted-by":"crossref","unstructured":"Varde, KS. Spray cone angle and its correlation in a high pressure fuel spray. Can J Chem Eng 1985;63:183\u20137. https:\/\/doi.org\/10.1002\/cjce.5450630202.","DOI":"10.1002\/cjce.5450630202"},{"key":"2025121816430082005_j_pp-2025-0008_ref_055","doi-asserted-by":"crossref","unstructured":"Rahimi-Gorji, M, Debbaut, C, Ghorbaniasl, G, Cosyns, S, Willaert, W, Ceelen, W, et al.. Optimization of intraperitoneal aerosolized drug delivery using computational fluid dynamics (CFD) modeling. Sci Rep 2022;12:6305. https:\/\/doi.org\/10.1038\/s41598-022-10369-8.","DOI":"10.1038\/s41598-022-10369-8"},{"key":"2025121816430082005_j_pp-2025-0008_ref_056","doi-asserted-by":"crossref","unstructured":"Huang, F, Zhu, Q, Zhou, X, Gou, D, Yu, J, Li, R, et al.. Role of CFD based in\u00a0silico modelling in establishing an in vitro-in vivo correlation of aerosol deposition in the respiratory tract. Adv Drug Deliv Rev 2021;170:369\u201385. https:\/\/doi.org\/10.1016\/j.addr.2020.09.007.","DOI":"10.1016\/j.addr.2020.09.007"},{"key":"2025121816430082005_j_pp-2025-0008_ref_057","doi-asserted-by":"crossref","unstructured":"Braet, H, Rahimi-Gorji, M, Debbaut, C, Ghorbaniasl, G, Van Walleghem, T, Cornelis, S, et al.. Exploring high pressure nebulization of pluronic F127 hydrogels for intraperitoneal drug delivery. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV 2021;169:134\u201343. https:\/\/doi.org\/10.1016\/j.ejpb.2021.10.001.","DOI":"10.1016\/j.ejpb.2021.10.001"},{"key":"2025121816430082005_j_pp-2025-0008_ref_058","doi-asserted-by":"crossref","unstructured":"Braet, H, Fransen, PP, Chen, Y, Van Herck, S, Mari\u00ebn, R, Vanhoorne, V, et al.. Smart hydrogels delivered by high pressure aerosolization can prevent peritoneal adhesions. J\u00a0Control Release Off J Control Release Soc 2023;362:138\u201350. https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.042.","DOI":"10.1016\/j.jconrel.2023.08.042"},{"key":"2025121816430082005_j_pp-2025-0008_ref_059","doi-asserted-by":"crossref","unstructured":"Kakchekeeva, T, Demtr\u00f6der, C, Herath, NI, Griffiths, D, Torkington, J, Sola\u00df, W, et al.. In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC). Ann Surg Oncol 2016;23:592\u20138. https:\/\/doi.org\/10.1245\/s10434-016-5108-4.","DOI":"10.1245\/s10434-016-5108-4"},{"key":"2025121816430082005_j_pp-2025-0008_ref_060","doi-asserted-by":"crossref","unstructured":"Reymond, M, Demtroeder, C, Solass, W, Winnekendonk, G, Tempfer, C. Electrostatic precipitation pressurized IntraPeritoneal aerosol chemotherapy (ePIPAC): first in-human application. Pleura Peritoneum 2016;1:109\u201316. https:\/\/doi.org\/10.1515\/pp-2016-0005.","DOI":"10.1515\/pp-2016-0005"},{"key":"2025121816430082005_j_pp-2025-0008_ref_061","doi-asserted-by":"crossref","unstructured":"Rauwerdink, P, van de Vlasakker, VCJ, Wassenaar, ECE, Rovers, KP, Los, M, Herbschleb, KH, et al.. First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II). Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 2024;50:108487. https:\/\/doi.org\/10.1016\/j.ejso.2024.108487.","DOI":"10.1007\/s00464-024-11185-z"},{"key":"2025121816430082005_j_pp-2025-0008_ref_062","doi-asserted-by":"crossref","unstructured":"Min, SH, Yoo, M, Hwang, D, Lee, E, Kang, SH, Lee, S, et al.. Hyperthermic pressurized intraperitoneal aerosol drug delivery system in a large animal model: a feasibility and safety study. Surg Endosc 2024;38:2062\u20139. https:\/\/doi.org\/10.1007\/s00464-024-10702-4.","DOI":"10.1007\/s00464-024-10702-4"},{"key":"2025121816430082005_j_pp-2025-0008_ref_063","doi-asserted-by":"crossref","unstructured":"Min, SH, Lee, J, Yoo, M, Hwang, D, Lee, E, Kang, SH, et al.. Efficacy of hyperthermic pressurized intraperitoneal aerosol chemotherapy in an in\u00a0vitro model using a human gastric cancer AGS cell line and an abdominal cavity model. J\u00a0Gastric Cancer 2024;24:246\u201356. https:\/\/doi.org\/10.5230\/jgc.2024.24.e24.","DOI":"10.5230\/jgc.2024.24.e24"},{"key":"2025121816430082005_j_pp-2025-0008_ref_064","doi-asserted-by":"crossref","unstructured":"Kockelmann, F, Giger-Pabst, U, Ouaissi, M, Bucur, P, Barbey, S, Von Ardenne, A, et al.. First clinical safety and feasibility data of whole-body hyperthermia pressurized intraperitoneal aerosol chemotherapy (WBH-PIPAC) for peritoneal surface malignancies. Anticancer Res 2024;44:3043\u201350. https:\/\/doi.org\/10.21873\/anticanres.17117.","DOI":"10.21873\/anticanres.17117"},{"key":"2025121816430082005_j_pp-2025-0008_ref_065","doi-asserted-by":"crossref","unstructured":"Khosrawipour, V, Reinhard, S, Martino, A, Khosrawipour, T, Arafkas, M, Mikolajczyk, A, et al.. Increased tissue penetration of doxorubicin in pressurized intraperitoneal aerosol chemotherapy (PIPAC) after high-intensity ultrasound (HIUS). Int J Surg Oncol 2019;2019:6185313. https:\/\/doi.org\/10.1155\/2019\/6185313.","DOI":"10.1155\/2019\/6185313"},{"key":"2025121816430082005_j_pp-2025-0008_ref_066","doi-asserted-by":"crossref","unstructured":"Mikolajczyk, A, Khosrawipour, V, Kulas, J, Kocielek, K, Migdal, P, Arafkas, M, et al.. Release of doxorubicin from its liposomal coating via high intensity ultrasound. Mol Clin Oncol 2019;11:483\u20137. https:\/\/doi.org\/10.3892\/mco.2019.1917.","DOI":"10.3892\/mco.2019.1917"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0008\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0008\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:52:07Z","timestamp":1766076727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0008\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,9,26]]},"published-print":{"date-parts":[[2025,12,16]]}},"alternative-id":["10.1515\/pp-2025-0008"],"URL":"https:\/\/doi.org\/10.1515\/pp-2025-0008","relation":{},"ISSN":["2364-768X"],"issn-type":[{"value":"2364-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]}}}